Inventor · disambiguated record
Patrice Gill
Also filed as: GILL PATRICE
15 granted patents·6 pending applications·39 citations·filing 2004–2022
89Inventor score
Top patents by PatentIndex Score
21 records- 0192US9273014B2Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Mar 1, 2016·14 cites·11 claims
- 0287US11344543B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2018·Granted May 31, 2022·2 cites·25 claims
- 0386US8999918B2Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereofBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 7, 2015·9 cites·19 claims
- 0481US7456194B2Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Nov 25, 2008·5 cites·6 claims
- 0579US9492460B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 15, 2016·4 cites·15 claims
- 0674US9751879B2Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 5, 2017·1 cites·13 claims
- 0773US12171756B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2022·Granted Dec 24, 2024·0 cites·10 claims
- 0867US7176214B2Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 13, 2007·3 cites·20 claims
- 0963US8148400B2Thiazolyl compounds useful as kinase inhibitorsMARINIER ANNE·Filed 2007·Granted Apr 3, 2012·1 cites·5 claims
- 1054US9187434B2Substituted 1,5-benzodiazepinones compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 17, 2015·0 cites·9 claims
- 1154US2006217412A1Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising samePITTS WILLIAM J·Filed 2006·Application pending·0 cites
- 1252US9242940B2N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 26, 2016·0 cites·8 claims
- 1352US2023127326A1C3-SUBSTITUTED 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1452US2023144824A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1552US2023118688A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1651US12187706B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Jan 7, 2025·0 cites·18 claims
- 1750US12338228B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Jun 24, 2025·0 cites·12 claims
- 1850US2023295087A1AGONISTS OF ROR GAMMAtBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1946US9427442B2Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 30, 2016·0 cites·7 claims
- 2046US2016318928A1Tricyclic compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2137US10174024B25H-pyrido[3,2-B]indole compounds as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 8, 2019·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →